Skip to main content
Clinical Trials/NCT03431116
NCT03431116
Completed
Not Applicable

The Prediction of Risk Factors of Progression of Low Implanted Placenta at 18- 24 Weeks to Placenta Previa at Term

Assiut University1 site in 1 country52 target enrollmentOctober 1, 2016
ConditionsPlacenta Previa

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Placenta Previa
Sponsor
Assiut University
Enrollment
52
Locations
1
Primary Endpoint
The distance between lower edge of the placenta and internal os by ultrasound (millimeter)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Placenta Previa is defined as a placenta implanted in the lower segment of the uterus, presenting ahead of the leading pole of the fetus (over or near the internal os). The prevalence of placenta previa has been estimated to be approximately 0.5% of all pregnancies, and this increase correlates to the elevated cesarean section rate . In Egypt, the prevalence of placenta previa is around 1.3% in Sohag Governorate and 1.5% in Aswan region according to.

Although various studies have tried to address risk factors associated with Placenta Previa development, the etiology of placenta previa still remains obscure. Several risk actors have been identified as strong contributors to placenta previa development. It is also a significant contributor to severe postpartum hemorrhage.Risk factors include; history of previous cesarean section, advanced maternal age, history of previous abortions, high parity and substance abuse during pregnancy (cigarette smoking), placental size (multiple pregnancy), endometrial damage (previous dilatation and curettage), uterine scars and pathology (previous myomectomy or endometritis), placental pathology (marginal cord insertions and succenturiate lobes), previous placental Previa, and curiously.

Registry
clinicaltrials.gov
Start Date
October 1, 2016
End Date
April 30, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohammed Khairy Ali

Lecturer

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Pregnant women between 18-24 weeks.
  • Diagnosed to have low implanted placenta by ultrasound

Exclusion Criteria

  • Patient refused to follow-up in our setting.
  • Patient refused to perform Trans-vaginal ultrasound in the second trimester of gestation.

Outcomes

Primary Outcomes

The distance between lower edge of the placenta and internal os by ultrasound (millimeter)

Time Frame: 12 weeks

Study Sites (1)

Loading locations...

Similar Trials